Izilda Aparecida Cardinalli

Izilda Aparecida Cardinalli

Auto-generated profile, based on publicly available information

Izilda Aparecida Cardinalli

Boldrini Children’s Center

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2021 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
LALady Paola Aristizabal Arboleda
Lady Paola Aristizabal Arboleda
CRCarla Isabelly Rodrigues‐Fernandes
Carla Isabelly Rodrigues‐Fernandes
BMBruno Augusto Linhares Almeida Mariz
Bruno Augusto Linhares Almeida Mariz
BABruno Augusto Benevenuto de Andrade
Bruno Augusto Benevenuto de Andrade
AAAline Corrêa Abrahão
Aline Corrêa Abrahão
Alan Roger Santos-SilvaAlan Roger Santos-Silva
Alan Roger Santos-Silva

26 March 2018 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KSKarina Bezerra Salomão
Karina Bezerra Salomão
GCGustavo Alencastro Veiga Cruzeiro
Gustavo Alencastro Veiga Cruzeiro
RBRicardo Bonfim-Silva
Ricardo Bonfim-Silva
LGLenisa Geron
Lenisa Geron
FRFernando Silva Ramalho
Fernando Silva Ramalho
LTLuiz Gonzaga Tone
Luiz Gonzaga Tone

1 January 2000 in Haematologia
Verified
Journal Article
Closed access
PDF file
CLCarmen Silvia Passos Lima
Carmen Silvia Passos Lima
JVJose Vassallo
Jose Vassallo
ICIzilda A. Cardinalli
Izilda A. Cardinalli
CSCarmino Antonio De Souza
Carmino Antonio De Souza
MCMarcelo L. da Cunha
Marcelo L. da Cunha
JNJorge V. Pinto Neto
Jorge V. Pinto Neto
Osteolytic lesions rarely occur in acute myeloid leukemia (AML). We reported an atypical form of the disease, with marrow fibrosis and osteolytic lesions, in a 17-year-old patient, whose main symptom was lumbar pain. Diagnosis of AML was established by bone marrow and lymph node histological analysis. Computed tomography (CT) scan and 99mTc-MDP bone scintyscan revealed osteolytic lesions. After remission-induction, bone marrow aspirate and biopsy showed no evidence of leukemic infiltration, nevertheless bone abnormalities persisted on 99mTc-MDP bone scintyscan, suggesting residual disease. Suspect bone areas were irradiated with symptomatic improvement and 99mTc-MDP bone scintyscan showed the appearance of more condensed bone compared with the pre-radiotherapy pattern. Twelve months later he was readmitted to the hospital due to relapse of AML and died of sepsis within a few weeks. This report illustrates the usefulness of histological studies to establish diagnosis of AML in atypical cases, as well as the importance of CT scan and bone scintigraphy scan for the identification of osteolytic lesions. It also provides additional data as evidence that although osteolytic lesions indicate an adverse prognosis in AML, local irradiation results symptomatic relief.

1 January 2021 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
PDF file
IHIva Loureiro Hoffmann
Iva Loureiro Hoffmann
ICIzilda Aparecida Cardinalli
Izilda Aparecida Cardinalli
JYJosé Andrés Yunes
José Andrés Yunes
ASAna Luiza Ongaro Seidinger
Ana Luiza Ongaro Seidinger
RPRicardo Mendes Pereira
Ricardo Mendes Pereira
Objective: To describe the clinical, demographic, anatomopathological, molecular, and survival characteristics of patients with medulloblastoma. Methods: Retrospective study based on patient information obtained from the review of medical records. Overall and event-free survival were analyzed using the Kaplan-Meier estimator, and the curves were compared by the log-rank test. Results: Among the patients investigated, 70 were male (66%), and age at diagnosis ranged from 2 months to 22 years. The most frequent signs and symptoms were headache (80.8%) and vomiting (75.8%). Regarding treatment, most patients (63.2%) underwent complete surgical resection, with a predominance of classic histology (63.2%). The 5-year overall survival rate was 67.9%, and the 10-year rate was 64.2%. Patients with molecular profile characteristic of the wingless (WNT) subgroup had a better prognosis, with 5-year overall survival of 75%. Conclusions: The clinical, demographic, anatomopathological, and molecular characteristics of patients with medulloblastoma described in the present study were mostly similar to those reported in the literature. Patients submitted to complete tumor resection had better clinical outcomes than those who underwent incomplete resection/biopsy. Patients classified as high-risk showed worse overall and event-free survival than those in the standard-risk group, and the presence of metastasis at diagnosis was associated with recurrence.

13 August 2025 in Cancer Biology & Therapy
Verified
Journal Article
Open access
LKLarissa Akemi Kido
Larissa Akemi Kido
MMMilena Rodrigues Marusco
Milena Rodrigues Marusco
ESEllen Aparecida da Silva
Ellen Aparecida da Silva
LCLaís Do Carmo
Laís Do Carmo
ABAna Beatriz Teodoro Borges
Ana Beatriz Teodoro Borges
PZPriscila Pini Zenatti
Priscila Pini Zenatti
Developing advanced preclinical models and targeted therapies is essential for reducing cancer-related deaths in children with solid tumors. Patient-derived xenografts (PDX) have the potential to replicate key elements of the original tumor, including morphology, genetic alterations, and microenvironment, making them valuable tools for studying tumor biology and drug response. We implanted 124 pediatric solid tumor samples, collected for 1 y, into NOD/SCID/IL2Rg (NSG) mice. Tumor fragments were placed subcutaneously, and the animals were monitored for up to 1 y. Histopathology, Short Tandem Repeat (STR) profiling, RT-PCR and/or RNA-sequencing were performed to confirm tumor identity and detect driver fusions. Fifty-five xenografts were successfully established (44.35% of implanted samples), representing 19 tumor types. Sarcomas, notably osteosarcoma, Ewing sarcoma, synovial sarcoma, and rhabdomyosarcoma, displayed first-generation engraftment rates above 55%. Central nervous system tumors had lower success, reflecting unique microenvironmental requirements. Histopathology and STR concordances were 85.45% and 81.1%, respectively, while 92.6% of sarcoma PDXs retained original fusion genes. Second-generation xenografts showed faster growth, suggesting adaptation to the murine host. Sporadic discrepancies, such as new fusions or lymphoproliferative expansions, indicated the need for ongoing molecular validation parallel to other techniques. A pediatric PDX biobank can effectively capture key tumor features while facilitating the study of therapeutic responses and tumor evolution. Our models confirm the feasibility of achieving stable histological and molecular profiles, offering a valuable resource for precision oncology research. Ultimately, these pediatric PDXs could accelerate the discovery of targeted therapy and significantly improve treatment outcomes.

15 June 2023 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
PAPaola Aristizabal Arboleda
Paola Aristizabal Arboleda
MPMaria Eduarda Pérez-De-Oliveira
Maria Eduarda Pérez-De-Oliveira
IHIva Loureiro Hoffmann
Iva Loureiro Hoffmann
ICIzilda Aparecida Cardinalli
Izilda Aparecida Cardinalli
KGKaren Patricia Dominguez Gallagher
Karen Patricia Dominguez Gallagher
Alan Roger Santos-SilvaAlan Roger Santos-Silva
Alan Roger Santos-Silva